Bruce Stroever - Sep 17, 2024 Form 4 Insider Report for Bone Biologics Corp (BBLG)

Role
Director
Signature
/s/ Bruce Stroever
Stock symbol
BBLG
Transactions as of
Sep 17, 2024
Transactions value $
$0
Form type
4
Date filed
9/19/2024, 09:33 PM
Previous filing
Sep 20, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BBLG Non-Employee Stock Option Award $0 +30.7K $0.00 30.7K Sep 17, 2024 Common Stock 30.7K $1.73 Direct F1
holding BBLG Non-Employee Stock Option 10.7K Sep 17, 2024 Common Stock 10.7K $5.12 Direct F2
holding BBLG Non-Employee Stock Option 154 Sep 17, 2024 Common Stock 154 $387.26 Direct F2
holding BBLG Non-Employee Stock Option 37 Sep 17, 2024 Common Stock 37 $844.80 Direct F2
holding BBLG Non-Employee Stock Option 13 Sep 17, 2024 Common Stock 13 $1,260.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests and becomes exercisable quarterly through the date of the next annual meeting of stockholders of the Company.
F2 This option is fully exercisable as of the date of this report.